Is Eravacycline Ready for Prime Time Against CRAB Pneumonia?
September 22nd 2022Eravacycline is an antibiotic that has been touted for possible treatment of difficult-to-treat resistant (DTR) Gram-negative infections. But can it tackle carbapenem-resistant Acinetobacter baumannii (CRAB) infections?
Read More
Improvement of Long-Term Outcomes of MSSA Bacteremia With Formal Infectious Disease Consults
March 3rd 2020Staphylococcus aureus is a major cause of both health care-acquired and community-acquired infections ranging from skin and soft tissue infections to more invasive infections like bacteremia
Read More
Comparing Effectiveness of Agents for MSSA Bacteremia
August 16th 2019Evidence demonstrates that antimicrobial therapy with an anti-staphylococcal β-lactam antibiotic is the gold standard for treatment of SAB caused by MSSA, but confusion about which agent—particularly cefazolin versus an anti-staphylococcal penicillin—is preferred remains an unanswered question
Read More